Free tool
Cell therapy stocks
We cover 8 companies grouped under the Cell therapy theme. The median market value in the group is $24.35M. Across the group, the median move over the past trading day is −2.14%. Price change over the past year runs from −60.8% to +13.2% across the middle 80 percent of the group, with a median of −45.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| V3V.DE | FamiCord AG | 2.85 EUR | −3.06% | −52.89% | −60.69% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | 580.00 GBP | −17.08% | +2.11% | +81.25% |
| PTG.WA | Poltreg S.A. | 25.20 PLN | +14.03% | −1.18% | −16.00% |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.06 EUR | −9.73% | −26.71% | −46.78% |
| 0NLV.L | FamiCord AG | 2.78 EUR | −1.55% | −53.28% | −61.12% |
| F98.F | CytoMed Therapeutics Limited | 0.75 EUR | −3.23% | −75.81% | −54.82% |
| 0QFK.L | Celyad Oncology SA | 0.26 EUR | −7.09% | +46.29% | −16.07% |
| BSFA.L | BSF Enterprise Plc | 1.25 GBP | +56.25% | −34.21% | −44.44% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.